Recurrence patterns and progression-free survival after chemoradiotherapy with or without consolidation durvalumab for stage III non-small cell lung cancer

Chemoradiotherapy followed by consolidation durvalumab (CCRT+D) improves survival in patients with stage III non-small-cell lung cancer (NSCLC). We compared recurrence patterns and survival in the CCRT+D and CCRT cohorts. We conducted a multicenter, retrospective study in Japan. Patients who receive...

Descripción completa

Detalles Bibliográficos
Autores principales: Kishi, Noriko, Matsuo, Yukinori, Shintani, Takashi, Ogura, Masakazu, Mitsuyoshi, Takamasa, Araki, Norio, Fujii, Kota, Okumura, Setsuko, Nakamatsu, Kiyoshi, Kishi, Takahiro, Atsuta, Tomoko, Sakamoto, Takashi, Ohtsu, Shuji, Katagiri, Tomohiro, Narabayashi, Masaru, Fujishiro, Satsuki, Iizuka, Yusuke, Ozasa, Hiroaki, Hirai, Toyohiro, Mizowaki, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Regular paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855316/
https://www.ncbi.nlm.nih.gov/pubmed/36149029
http://dx.doi.org/10.1093/jrr/rrac057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855316/
https://www.ncbi.nlm.nih.gov/pubmed/36149029
http://dx.doi.org/10.1093/jrr/rrac057

Ejemplares similares